Skip to main navigation menu Skip to main content Skip to site footer

Chronic use of non-steroidal anti-inflammatory drugs and its association with the development of hypertensive crisis: a narrative review

Consumo crónico de antiinflamatorios no esteroideos y su relación con el desarrollo de crisis hipertensiva: una revisión narrativa





Section
Research Articles

How to Cite
Avila Medrano, J. S., & Doria Galvis, J. D. (2024). Chronic use of non-steroidal anti-inflammatory drugs and its association with the development of hypertensive crisis: a narrative review. Archivos De Medicina (Manizales), 23(2). https://doi.org/10.30554/archmed.23.2.4884.2023
Download Citation

Dimensions
PlumX

How to Cite

Avila Medrano, J. S., & Doria Galvis, J. D. (2024). Chronic use of non-steroidal anti-inflammatory drugs and its association with the development of hypertensive crisis: a narrative review. Archivos De Medicina (Manizales), 23(2). https://doi.org/10.30554/archmed.23.2.4884.2023

Download Citation

Juan Sebastian Avila Medrano
Jesus David Doria Galvis

Introduction: Arterial hypertension is defined as high blood pressure, generally speaking of a systolic that reaches at least 140 mmHg and/or an elevation of diastolic blood pressure of at least 90 mmHg. For its part, hypertensive crisis does not have a standardized definition, but it is known as a sudden or acute increase in blood pressure with compromise of the target organ.

Objectives: The main objective of this study was to describe the chronic consumption of non-steroidal anti-inflammatory drugs and its relationship with the development of hypertensive crises.

Discussion: Around 10 studies were found that report increased systolic and diastolic pressure after the consumption of certain NSAIDs such as naproxen, ibuprofen and indomethacin. The increase in pressure for this group of drugs ranges from 14 to 20%.

Conclusion: NSAIDs do not reach the necessary levels for the induction of a hypertensive crisis, however, there is limited literature that reports possible cases of hypertensive crisis secondary to the use of these, for this reason, it is relevant to expand the study of the possibility of crises. hypertensive. for this pharmacological group.


Article visits 605 | PDF visits 458


Downloads

Download data is not yet available.
  1. Ipek, E., Oktay, AA y Krim, SR. Crisis hipertensiva. Opinión actual en cardiología. 2017; 32(4), 397–406. doi:10.1097/hco.0000000000000398
  2. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560–2572
  3. Caldevilla Bernardo David, Martínez Pérez Josefa, Artigao Rodenas Luis Miguel, Divisón Garrote Juan Antonio, Carbayo Herencia Julio Antonio, Massó Orozco Javier. Crisis Hipertensivas. Rev Clin Med Fam. 2008; 2( 5 ): 236-243.
  4. Muiesan ML, Salvetti M, Amadoro V, et al. An update on hypertensive emergencies and urgencies. J Cardiovasc Med 2015; 16:372–382.
  5. Johnson W, Nguyen M Le, Patel R. Hypertension crisis in the emergency department. Cardiol Clin 2012; 30:533–543.
  6. Szeto CC, Sugano K, Wang JG, et al. Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: jointAPAGE/APLAR/APSDE/APSH/APSN/PoA recommendations. Gut. 2020; 69(4):617-629
  7. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020 Oct;180:114147. doi: 10.1016/j.bcp.2020.114147.
  8. García-Rayado G, Navarro M, Lanas A. NSAID induced gastrointestinal damage and designing GI-sparing NSAIDs. Expert Rev Clin Pharmacol. 2018;11(10):1031-1043.
  9. Jahangiri, S, & et al. Prevalence of non-steroidal anti-inflammatory drugs (NSAIDs) use in patients with hypertensive crisis. Health SCI rEP. 2022;5(1).
  10. Solomon, Daniel H., Christopher P. Cannon, and G. M. Saperia. "NSAIDs: adverse cardiovascular effects." UpToDate. Waltham, MA: UpToDate (2020).
  11. Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly. Aging Dis. 2018 Feb 1;9(1):143-150. doi: 10.14336/AD.2017.0306. PMID: 29392089; PMCID: PMC5772852
  12. Ruschitzka F, Borer JS, Krum H, et al. Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISIONABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial.Eur Heart J 2017;38(44):3282–92.
  13. Townsend, Raymond R., and George L. Bakris. "NSAIDs and acetaminophen: effects on blood pressure and hypertension." (2017)
  14. Johnson, A.G. NSAIDs and Increased Blood Pressure. Drug-Safety 17, 277–289 (1997). https://doi.org/10.2165/00002018-199717050-00001
  15. Foy, Matthew C., Joban Vaishnav, and Christopher John Sperati. "Drug-induced hypertension." Endocrinology and Metabolism Clinics 48.4 (2019): 859-873.
  16. Snowden S, Nelson R. The effects of nonsteroidal anti-inflammatory drugs on blood pressure in hypertensive patients. Cardiol Rev. 2011 Jul-Aug;19(4):184-91. doi: 10.1097/CRD.0b013e31821ddcf4. PMID: 21646872.
  17. Masi, Stefano, et al. "Drug-induced hypertension: Know the problem to know how to deal with it." Vascular pharmacology 115 (2019): 84-88
  18. Liew, Jean W., et al. "Nonsteroidal antiinflammatory drug use and association with incident hypertension in ankylosing spondylitis." Arthritis care & research 72.11 (2020): 1645-1652.
  19. Ruschitzka F, Borer JS, Krum H, Flammer AJ, Yeomans ND, Libby P, Lüscher TF, Solomon DH, Husni ME, Graham DY, Davey DA, Wisniewski LM, Menon V, Fayyad R, Beckerman B, Iorga D, Lincoff AM, Nissen SE. Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial. Eur Heart J. 2017 Nov 21;38(44):3282-3292. doi: 10.1093/eurheartj/ehx508. PMID: 29020251; PMCID: PMC8139400
  20. Solomon, Daniel H., et al. "Differences in safety of nonsteroidal antiinflammatory drugs in patients with osteoarthritis and patients with rheumatoid arthritis: a randomized clinical trial." Arthritis & Rheumatology 70.4 (2018): 537-546.
  21. Tran, Lina. "Harmful Effects of NSAIDs among Patients with Hypertension and Coronary Artery Disease: Bavry AA, Khaliqu A, Gong Y, et al. Am J Med 2011; 124: 614–20." Journal of Emergency Medicine 42.2 (2012): 241-242
  22. Aljadhey, H., Tu, W., Hansen, R.A. et al. Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension. BMC Cardiovasc Disord 12, 93 (2012). https://doi.org/10.1186/1471-2261-12-93
  23. Hsu CC, Wang H, Hsu YH, Chuang SY, Huang YW, Chang YK, Liu JS, Hsiung CA, Tsai HJ. Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Subjects With Hypertension: Nationwide Longitudinal Cohort Study. Hypertension. 2015 Sep;66(3):524-33. doi: 10.1161/HYPERTENSIONAHA.114.05105. Epub 2015 Jul 13. PMID: 26169048
  24. Leiba A, Cohen-Arazi O, Mendel L, Holtzman EJ, Grossman E. Incidence, aetiology and mortality secondary to hypertensive emergencies in a large-scale referral centre in Israel (1991-2010). J Hum Hypertens. 2016 Aug;30(8):498-502. doi: 10.1038/jhh.2015.115. Epub 2015 Dec 17. PMID: 26674757.
  25. Fernandez, M. Palazuelos, V. Macias, B. Castro, F. Manejo de la hipertensión arterial en Urgencias. Medicine. 2015;11(90):5371-8
  26. Batlouni, M. Antiinflamatorios No Esteroides: Efectos Cardiovasculares,Cerebrovasculares y Renales. Arq Bras Cardiol 2010;94(4): 538-546
  27. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med. 1993; 153: 477-84
  28. Hervas, A. Emergencia hipertensiva, secundaria a la toma de AINE. Aten Primaria 2004;34(5)
  29. Vasco, M. Vigil, P. Abordaje del anestesiólogo en pacientes con hipertensión y embarazo. Rev Obstet Ginecol Venez 2014;74(1):15-23
  30. Wallbach, M. Et al. Direct assessment of adherence and drug interactions in patients with hypertensive crisis—A cross‐sectional study in the Emergency Department. J Clin Hypertens. 2019;21:55–63.
  31. Dhungana B, Kansakar S, Paudel P, et al. Indomethacin-Induced Hypertensive Crisis. Cureus. 2021. 13(9): e18043.